Know the questions to ask your doctor about metastatic prostate cancer, such as treatment options, lifestyle changes, and ...

Learn about medications, surgery, radiation, exercise, and other therapies and strategies for symptom relief from advanced ...

Tumor DNA profiling could be used to identify which men with metastatic prostate cancer need aggressive treatment and those who may benefit from de-escalation.A model, trained and tested on nearly ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...

When a patient learns they have metastatic castration-sensitive prostate cancer (mCSPC), it often marks the beginning of a ...

About 1 in 8 men are diagnosed with prostate cancer during their lifetime. Although many survive, it can develop into metastatic disease.

For men with genitourinary malignancies, such as prostate cancer, examining the external genital area is essential. While this may seem routine, it remains a crucial recommendation, as illustrated by ...

Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...

Prostate cancer patients experience a plethora of cardiovascular risk factors.  If left untreated, these conditions can lead ...